Beth L Nordstrom

Summary

Affiliation: Ingenix Epidemiology
Country: USA

Publications

  1. ncbi Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Curr Med Res Opin 21:761-8. 2005
  2. ncbi Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Mass, USA
    Antivir Ther 9:187-95. 2004
  3. ncbi Persistence and adherence with topical glaucoma therapy
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Massachusetts 02466, USA
    Am J Ophthalmol 140:598-606. 2005
  4. ncbi Health outcomes among patients receiving oseltamivir
    Cheryl Enger
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 13:227-37. 2004
  5. ncbi The impact of wording in "Dear doctor" letters and in black box labels
    Lisa Bianchi Weatherby
    Epidemiology Division, Ingenix, Newton, MA 02466, USA
    Clin Pharmacol Ther 72:735-42. 2002
  6. ncbi Identification of abacavir hypersensitivity reaction in health care claims data
    Beth L Nordstrom
    i3 Drug Safety, Auburndale, MA, USA
    Pharmacoepidemiol Drug Saf 16:289-96. 2007

Detail Information

Publications6

  1. ncbi Risk of pneumonia and other complications of influenza-like illness in patients treated with oseltamivir
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Curr Med Res Opin 21:761-8. 2005
    ..Clinical trials suggest that the risk of pneumonia and other sequelae of influenza may be reduced in patients using oseltamivir...
  2. ncbi Skin reactions in patients with influenza treated with oseltamivir: a retrospective cohort study
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Mass, USA
    Antivir Ther 9:187-95. 2004
    ..It is concluded that oseltamivir use does not appear to be associated with an increased risk of skin reactions...
  3. ncbi Persistence and adherence with topical glaucoma therapy
    Beth L Nordstrom
    Ingenix Epidemiology, Auburndale, Massachusetts 02466, USA
    Am J Ophthalmol 140:598-606. 2005
    ..The present study describes the patterns and predictors of treatment persistence and adherence among patients who are diagnosed with glaucoma or as glaucoma suspects (based on claims codes)...
  4. ncbi Health outcomes among patients receiving oseltamivir
    Cheryl Enger
    Ingenix Epidemiology, Auburndale, MA 02466, USA
    Pharmacoepidemiol Drug Saf 13:227-37. 2004
    ..CONCLUSIONS: There appears to be no increased risk of cardiac or neuropsychiatric outcomes among subjects with influenza who were treated with oseltamivir in comparison with those who were not...
  5. ncbi The impact of wording in "Dear doctor" letters and in black box labels
    Lisa Bianchi Weatherby
    Epidemiology Division, Ingenix, Newton, MA 02466, USA
    Clin Pharmacol Ther 72:735-42. 2002
    ....
  6. ncbi Identification of abacavir hypersensitivity reaction in health care claims data
    Beth L Nordstrom
    i3 Drug Safety, Auburndale, MA, USA
    Pharmacoepidemiol Drug Saf 16:289-96. 2007
    ..Identification of this reaction through medical insurance claims could provide a simple and efficient means of monitoring the incidence of abacavir hypersensitivity in large populations of patients...